Mobile

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre, Long-Term Study to Evaluate the Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000091-14

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre, Long-Term Study to Evaluate the Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for 52 Weeks in Adult and Adolescent Subjects with Perennial Allergic Rhinitis

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to assess the safety and tolerability of 12 months treatment with intranasal GW685698X 100mcg once daily (QD) in subjects >=12 years of age with PAR.

Critère d'inclusion

  • Perennial allergic rhinitis

Liens